Results 221 to 230 of about 110,473 (315)

Combined targeting poly (ADP-ribose) polymerase and receptor tyrosine kinase inhibits ovarian clear cell carcinoma progression through disrupted ribosome biogenesis. [PDF]

J Mol Med (Berl)
Lin CY, Chao AS, Chao A, Wu RC, Yu AL, Fu CH, Teng YC, Huang RY, Lai CH.   +8 more
europepmc   +1 more source

Progesterone Enhances the Sensitivity of Ovarian Cancer Cells to Poly (ADP-Ribose) Polymerase (PARP) Inhibitors by Suggesting a Role for Transcription-Replication Conflict-Related Pathways: An In Vitro Study. [PDF]

Cureus
Suizu E, Koyanagi T, Saga Y, Takahashi Y, Tamura K, Taneichi A, Takei Y, Mizukami H, Fujiwara H.   +8 more
europepmc   +1 more source

The effects of organic solvents on poly(ADP-ribose) polymerase-1 activity: implications for neurotoxicity

, 2004
Marek Banasik, Todd Stedeford, Robert P. Strosznajder, Amanda S. Persad, Seigo Tanaka, Kunihiro Ueda   +5 more
openalex   +2 more sources

Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro [PDF]

, 2001
Karen J. Bowman, David R. Newell, A. Hilary Calvert, Nicola J. Curtin   +3 more
openalex   +1 more source

Poly(ADP-ribose) polymerase (PARP) inhibitors and ovarian cancer

Taiwanese Journal of Obstetrics & Gynecology, 2017
Chia-Hao Liu, Yi Chang
doaj   +1 more source

Poly (ADP-Ribose) Polymerase Inhibition Attenuates Atherosclerotic Plaque Development in ApoE-/- Mice with Hyperhomocysteinemia. [PDF]

J Atheroscler Thromb
Xie JJ, Yu X, Liao YH, Chen J, Yao R, Chen Y, Liao MY, Ding YJ, Tang TT, Cheng X.   +9 more
europepmc   +1 more source

Targeting BRCA1 Localization to Augment Breast Tumor Sensitivity to Poly(ADP-Ribose) Polymerase Inhibition

, 2012
Eddy S. Yang, Somaira Nowsheen, Mohammad Aminur Rahman, Rebecca S. Cook, Fen Xia   +4 more
openalex   +2 more sources

Targeting PARP1: A Promising Approach for Next-Generation Poly (ADP-ribose) Polymerase Inhibitors. [PDF]

Curr Breast Cancer Rep
Ray A, Opyrchal M.
europepmc   +1 more source

Emerging Therapeutic Synergies: Combining PD-1 Inhibitors With Poly-ADP-Ribose Polymerase (PARP) Inhibitors in the Treatment of Gynecologic Cancers. [PDF]

Cureus
Mohamed Azhar MS, Loh Z, Mutamba FT, Algahiny A, Yunusa NM, Paramasevon S, Almusarhed M.   +6 more
europepmc   +1 more source

Establishment of poly(ADP-ribose) polymerase-deficient mouse embryonic stem cell lines

, 1998
Mitsuko Masutani, Tadashige Nozaki, Eiko Nishiyama, Takahiro Ochiya, Hitoshi Nakagama, Keiji Wakabayashi, Hiroshi Suzuki, Takashi Sügimura   +7 more
openalex   +2 more sources